Log in to save to my catalogue

Medroxyprogesterone acetate used in ovarian stimulation is associated with reduced mature oocyte ret...

Medroxyprogesterone acetate used in ovarian stimulation is associated with reduced mature oocyte ret...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7492309

Medroxyprogesterone acetate used in ovarian stimulation is associated with reduced mature oocyte retrieval and blastocyst development: a matched cohort study of 825 freeze-all IVF cycles

About this item

Full title

Medroxyprogesterone acetate used in ovarian stimulation is associated with reduced mature oocyte retrieval and blastocyst development: a matched cohort study of 825 freeze-all IVF cycles

Publisher

New York: Springer US

Journal title

Journal of assisted reproduction and genetics, 2020-09, Vol.37 (9), p.2337-2345

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Purpose
To compare the effectivity of flexible-start medroxyprogesterone acetate (MPA) co-treatment ovarian stimulations (OS) with flexible-start gonadotropin-releasing hormone antagonist (GnRH-ant) co-treatment OS, in blastocyst freeze-all IVF cycles.
Method
This matched cohort study was performed at a single IVF center. Study cycles were...

Alternative Titles

Full title

Medroxyprogesterone acetate used in ovarian stimulation is associated with reduced mature oocyte retrieval and blastocyst development: a matched cohort study of 825 freeze-all IVF cycles

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7492309

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7492309

Other Identifiers

ISSN

1058-0468

E-ISSN

1573-7330

DOI

10.1007/s10815-020-01894-4

How to access this item